Leukapheresis Market Size to Hit $98 million by 2027 – Exclusive Report by MarketsandMarkets™
Chicago, Nov. 16, 2022 (GLOBE NEWSWIRE) — According to the new market research report published by MarketsandMarkets, “Leukapheresis Market by Product (Devices, Filters, Membrane Separators), Leukopak (Mobilized, Non-Mobilized), Indication (ALL, NHL, Multiple Myeloma), Application (Research, Therapeutic), End User (Hospitals, Pharma, Biotech) – Global Forecast to 2027″, the global leukapheresis market is projected to reach USD 98 Million by 2027 from USD 65 Million in 2022, at a CAGR of 8.5%. The global leukopaks market is projected to reach USD 784 Million by 2027 from USD 146 Million in 2022, at a CAGR of 39.8%.
Browse in-depth TOC on “Leukapheresis Market“
226 – Tables
76 – Figures
294 – Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=20283148
Scope of the Report:
| Report Coverage | Details |
| Market Size | USD 98 million by 2027 |
| CAGR | 8.5% |
| Historical Data | 2020-2027 |
| Base Year | 2021 |
| Forecast Period | 2022-2027 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Leukapheresis Products – By Type, By application, By end user, By region Leukopaks – By Type, By indication, By end user, By region |
| Geographies Covered | North America, Europe, APAC, and Rest of the World |
| Key Companies Profiled/Vendors |
|
| Key Market Opportunities | Emerging economies with investments from academic institutes, pharma-biotech companies, and leading players |
| Key Market Drivers | Rising incidence and prevalence of leukemia |
The increasing focus on research applications of leukopaks, increasing leukemia incidence, and more blood donations for research purposes, are some of the factors driving market growth.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=20283148
In this report, the Leukapheresis Market is divided into two sub-markets, the Leukapheresis Products Market and the Leukopaks Market. The Leukapheresis Products Market is classified into four segments—type, application, end user, and region, and the Leukopaks Market is classified into four segments—type, indication, end user, and region.
Based on type, the leukapheresis products market has been segmented into devices and disposables. The rising use of leukapheresis disposables in isolating PBMCs and collecting leukopaks for research, recurrent demand of leukapheresis disposables, and rising leukapheresis based therapies for cancers, are some key drivers of the market.
Based on device type, the leukapheresis products market has been segmented into centrifugal devices, and membrane separators. The centrifugal devices segment holds the larger share of the leukapheresis products market. The large share of the centrifugal devices segment can be attributed to the increasing installation of centrifugal apheresis devices in hospitals for therapeutic apheresis.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=20283148
Geographical Growth Scenario:
In 2021, North America accounted for the largest share of the leukapheresis market, followed by Europe and the Asia Pacific. The large share of North America can be attributed to factors such as the developed health infrastructure in the US and Canada, and easy access to advanced blood separation devices. The leukapheresis market in the Asia Pacific region is estimated to register the highest CAGR during the forecast period. The high growth of the Asia Pacific region is attributed to the rising number of regenerative medicine and cell therapy research activities, and the betterment of life science research infrastructure in Asia Pacific countries.
Key Players:
Key players in the leukapheresis products market include Asahi Kasei Corporation (Japan), Fresenius SE & Co. KGaA (Germany), Haemonetics Corporation (US), Terumo BCT, Inc. (US), Macopharma SA (France), and Miltenyi Biotec (Germany).
Some prominent players in the leukopaks market are Discovery Life Sciences (US), StemExpress, LLC (US), Charles River Laboratories International, Inc. (US), Caltag Medsystems Limited (UK), Lonza Group AG (Switzerland), and ZenBio (US)
These companies adopted strategies such as product launches, business expansions, agreements, partnerships, and acquisitions to strengthen their presence in the Leukapheresis market.
Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting
Browse Related Reports:
Plasma Fractionation Market
3D Cell Culture Market
Blood Culture Tests Market
Apheresis Market
US Therapeutic Plasma Exchange Market
CONTACT: About MarketsandMarkets™ MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: [email protected]
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. NewIndiaObserver.com takes no editorial responsibility for the same.